0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38L7165
Home | Market Reports | Health| Medical Devices & Equipment
Global Interventional X ray Contrast and Imaging Agents Market Insights Forecast to 2028
BUY CHAPTERS

Global Interventional X-ray Contrast and Imaging Agents Market Insights, Forecast to 2030

Code: QYRE-Auto-38L7165
Report
December 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Interventional X-ray Contrast and Imaging Agents Market

A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging.
The global Interventional X-ray Contrast and Imaging Agents market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Interventional X-ray Contrast and Imaging Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Interventional X-ray Contrast and Imaging Agents include Bracco, General Electric, Guerbet, Fujifilm Visualsonics, Imax, J.B. Chemicals & Pharmaceuticals, Jodas Expoim, Lantheus Medical Imaging and Nano Therapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Interventional X-ray Contrast and Imaging Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Interventional X-ray Contrast and Imaging Agents, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Interventional X-ray Contrast and Imaging Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Interventional X-ray Contrast and Imaging Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Interventional X-ray Contrast and Imaging Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Interventional X-ray Contrast and Imaging Agents sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Interventional X-ray Contrast and Imaging Agents Market Report

Report Metric Details
Report Name Interventional X-ray Contrast and Imaging Agents Market
Segment by Type
Segment by Application
  • Heart Disease
  • Neurological
  • Urology
  • General Surgery
  • Other
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Guerbet, Fujifilm Visualsonics, Imax, J.B. Chemicals & Pharmaceuticals, Jodas Expoim, Lantheus Medical Imaging, Nano Therapeutics, Novalek Pharmaceuticals, Taejoon Pharm, Unijules Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Interventional X-ray Contrast and Imaging Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Interventional X-ray Contrast and Imaging Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interventional X-ray Contrast and Imaging Agents sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Interventional X-ray Contrast and Imaging Agents Market report?

Ans: The main players in the Interventional X-ray Contrast and Imaging Agents Market are Guerbet, Fujifilm Visualsonics, Imax, J.B. Chemicals & Pharmaceuticals, Jodas Expoim, Lantheus Medical Imaging, Nano Therapeutics, Novalek Pharmaceuticals, Taejoon Pharm, Unijules Life Sciences

What are the Application segmentation covered in the Interventional X-ray Contrast and Imaging Agents Market report?

Ans: The Applications covered in the Interventional X-ray Contrast and Imaging Agents Market report are Heart Disease, Neurological, Urology, General Surgery, Other

What are the Type segmentation covered in the Interventional X-ray Contrast and Imaging Agents Market report?

Ans: The Types covered in the Interventional X-ray Contrast and Imaging Agents Market report are Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Other

Recommended Reports

Contrast Media

X-Ray Equipment

Imaging Solutions

1 Study Coverage
1.1 Interventional X-ray Contrast and Imaging Agents Product Introduction
1.2 Market by Type
1.2.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Iodinated Contrast Media
1.2.3 Barium-Based Contrast Media
1.2.4 Microbubble Contrast Media
1.2.5 Other
1.3 Market by Application
1.3.1 Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Heart Disease
1.3.3 Neurological
1.3.4 Urology
1.3.5 General Surgery
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Interventional X-ray Contrast and Imaging Agents Sales Estimates and Forecasts 2019-2030
2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region
2.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2019-2024)
2.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2025-2030)
2.2.4 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2019-2030)
2.3 Global Interventional X-ray Contrast and Imaging Agents Sales Estimates and Forecasts 2019-2030
2.4 Global Interventional X-ray Contrast and Imaging Agents Sales by Region
2.4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2019-2024)
2.4.3 Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2025-2030)
2.4.4 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers
3.1.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers (2019-2024)
3.1.2 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Interventional X-ray Contrast and Imaging Agents in 2023
3.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers
3.2.1 Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2019-2024)
3.2.2 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Interventional X-ray Contrast and Imaging Agents Revenue in 2023
3.3 Global Key Players of Interventional X-ray Contrast and Imaging Agents, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Interventional X-ray Contrast and Imaging Agents Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Product Offered and Application
3.8 Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Type
4.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Type (2019-2024)
4.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Type (2025-2030)
4.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
4.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Type
4.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Type (2019-2024)
4.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Type (2025-2030)
4.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
4.3 Global Interventional X-ray Contrast and Imaging Agents Price by Type
4.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Type (2019-2024)
4.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Interventional X-ray Contrast and Imaging Agents Sales by Application
5.1.1 Global Interventional X-ray Contrast and Imaging Agents Historical Sales by Application (2019-2024)
5.1.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Sales by Application (2025-2030)
5.1.3 Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
5.2 Global Interventional X-ray Contrast and Imaging Agents Revenue by Application
5.2.1 Global Interventional X-ray Contrast and Imaging Agents Historical Revenue by Application (2019-2024)
5.2.2 Global Interventional X-ray Contrast and Imaging Agents Forecasted Revenue by Application (2025-2030)
5.2.3 Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
5.3 Global Interventional X-ray Contrast and Imaging Agents Price by Application
5.3.1 Global Interventional X-ray Contrast and Imaging Agents Price by Application (2019-2024)
5.3.2 Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Interventional X-ray Contrast and Imaging Agents Market Size by Type
6.1.1 US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
6.1.2 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
6.2 US & Canada Interventional X-ray Contrast and Imaging Agents Market Size by Application
6.2.1 US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
6.2.2 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
6.3 US & Canada Interventional X-ray Contrast and Imaging Agents Market Size by Country
6.3.1 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
6.3.3 US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Type
7.1.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
7.1.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
7.2 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Application
7.2.1 Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
7.2.2 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
7.3 Europe Interventional X-ray Contrast and Imaging Agents Market Size by Country
7.3.1 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
7.3.3 Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Interventional X-ray Contrast and Imaging Agents Market Size
8.1.1 China Interventional X-ray Contrast and Imaging Agents Sales (2019-2030)
8.1.2 China Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030)
8.2 China Interventional X-ray Contrast and Imaging Agents Market Size by Application
8.2.1 China Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
8.2.2 China Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Interventional X-ray Contrast and Imaging Agents Market Size by Type
9.1.1 Asia Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
9.1.2 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
9.2 Asia Interventional X-ray Contrast and Imaging Agents Market Size by Application
9.2.1 Asia Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
9.2.2 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
9.3 Asia Interventional X-ray Contrast and Imaging Agents Sales by Region
9.3.1 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Interventional X-ray Contrast and Imaging Agents Revenue by Region (2019-2030)
9.3.3 Asia Interventional X-ray Contrast and Imaging Agents Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Type
10.1.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Market Size by Application
10.2.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country
10.3.1 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bracco
11.1.1 Bracco Company Information
11.1.2 Bracco Overview
11.1.3 Bracco Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bracco Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bracco Recent Developments
11.2 General Electric
11.2.1 General Electric Company Information
11.2.2 General Electric Overview
11.2.3 General Electric Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 General Electric Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 General Electric Recent Developments
11.3 Guerbet
11.3.1 Guerbet Company Information
11.3.2 Guerbet Overview
11.3.3 Guerbet Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Guerbet Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Guerbet Recent Developments
11.4 Fujifilm Visualsonics
11.4.1 Fujifilm Visualsonics Company Information
11.4.2 Fujifilm Visualsonics Overview
11.4.3 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Fujifilm Visualsonics Recent Developments
11.5 Imax
11.5.1 Imax Company Information
11.5.2 Imax Overview
11.5.3 Imax Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Imax Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Imax Recent Developments
11.6 J.B. Chemicals & Pharmaceuticals
11.6.1 J.B. Chemicals & Pharmaceuticals Company Information
11.6.2 J.B. Chemicals & Pharmaceuticals Overview
11.6.3 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 J.B. Chemicals & Pharmaceuticals Recent Developments
11.7 Jodas Expoim
11.7.1 Jodas Expoim Company Information
11.7.2 Jodas Expoim Overview
11.7.3 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jodas Expoim Recent Developments
11.8 Lantheus Medical Imaging
11.8.1 Lantheus Medical Imaging Company Information
11.8.2 Lantheus Medical Imaging Overview
11.8.3 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lantheus Medical Imaging Recent Developments
11.9 Nano Therapeutics
11.9.1 Nano Therapeutics Company Information
11.9.2 Nano Therapeutics Overview
11.9.3 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nano Therapeutics Recent Developments
11.10 Novalek Pharmaceuticals
11.10.1 Novalek Pharmaceuticals Company Information
11.10.2 Novalek Pharmaceuticals Overview
11.10.3 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novalek Pharmaceuticals Recent Developments
11.11 Taejoon Pharm
11.11.1 Taejoon Pharm Company Information
11.11.2 Taejoon Pharm Overview
11.11.3 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Taejoon Pharm Recent Developments
11.12 Unijules Life Sciences
11.12.1 Unijules Life Sciences Company Information
11.12.2 Unijules Life Sciences Overview
11.12.3 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Unijules Life Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Interventional X-ray Contrast and Imaging Agents Industry Chain Analysis
12.2 Interventional X-ray Contrast and Imaging Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Interventional X-ray Contrast and Imaging Agents Production Mode & Process
12.4 Interventional X-ray Contrast and Imaging Agents Sales and Marketing
12.4.1 Interventional X-ray Contrast and Imaging Agents Sales Channels
12.4.2 Interventional X-ray Contrast and Imaging Agents Distributors
12.5 Interventional X-ray Contrast and Imaging Agents Customers
13 Market Dynamics
13.1 Interventional X-ray Contrast and Imaging Agents Industry Trends
13.2 Interventional X-ray Contrast and Imaging Agents Market Drivers
13.3 Interventional X-ray Contrast and Imaging Agents Market Challenges
13.4 Interventional X-ray Contrast and Imaging Agents Market Restraints
14 Key Findings in The Global Interventional X-ray Contrast and Imaging Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Iodinated Contrast Media
    Table 3. Major Manufacturers of Barium-Based Contrast Media
    Table 4. Major Manufacturers of Microbubble Contrast Media
    Table 5. Major Manufacturers of Other
    Table 6. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Interventional X-ray Contrast and Imaging Agents Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Interventional X-ray Contrast and Imaging Agents Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2019-2024)
    Table 11. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2025-2030)
    Table 12. Global Interventional X-ray Contrast and Imaging Agents Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2019-2024) & (K MT)
    Table 14. Global Interventional X-ray Contrast and Imaging Agents Sales by Region (2025-2030) & (K MT)
    Table 15. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2019-2024)
    Table 16. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2025-2030)
    Table 17. Global Interventional X-ray Contrast and Imaging Agents Sales by Manufacturers (2019-2024) & (K MT)
    Table 18. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Manufacturers (2019-2024)
    Table 19. Global Interventional X-ray Contrast and Imaging Agents Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Interventional X-ray Contrast and Imaging Agents, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Interventional X-ray Contrast and Imaging Agents Price by Manufacturers 2019-2024 (USD/MT)
    Table 23. Global Interventional X-ray Contrast and Imaging Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Interventional X-ray Contrast and Imaging Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional X-ray Contrast and Imaging Agents as of 2023)
    Table 25. Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Product Offered and Application
    Table 27. Global Key Manufacturers of Interventional X-ray Contrast and Imaging Agents, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2024) & (K MT)
    Table 30. Global Interventional X-ray Contrast and Imaging Agents Sales by Type (2025-2030) & (K MT)
    Table 31. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Type (2019-2024)
    Table 32. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Type (2025-2030)
    Table 33. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Interventional X-ray Contrast and Imaging Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Type (2019-2024)
    Table 36. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Type (2025-2030)
    Table 37. Interventional X-ray Contrast and Imaging Agents Price by Type (2019-2024) & (USD/MT)
    Table 38. Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Type (2025-2030) & (USD/MT)
    Table 39. Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2024) & (K MT)
    Table 40. Global Interventional X-ray Contrast and Imaging Agents Sales by Application (2025-2030) & (K MT)
    Table 41. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Application (2019-2024)
    Table 42. Global Interventional X-ray Contrast and Imaging Agents Sales Share by Application (2025-2030)
    Table 43. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Interventional X-ray Contrast and Imaging Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Application (2019-2024)
    Table 46. Global Interventional X-ray Contrast and Imaging Agents Revenue Share by Application (2025-2030)
    Table 47. Interventional X-ray Contrast and Imaging Agents Price by Application (2019-2024) & (USD/MT)
    Table 48. Global Interventional X-ray Contrast and Imaging Agents Price Forecast by Application (2025-2030) & (USD/MT)
    Table 49. US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2024) & (K MT)
    Table 50. US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Type (2025-2030) & (K MT)
    Table 51. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2024) & (K MT)
    Table 54. US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Application (2025-2030) & (K MT)
    Table 55. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2024) & (K MT)
    Table 61. US & Canada Interventional X-ray Contrast and Imaging Agents Sales by Country (2025-2030) & (K MT)
    Table 62. Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2024) & (K MT)
    Table 63. Europe Interventional X-ray Contrast and Imaging Agents Sales by Type (2025-2030) & (K MT)
    Table 64. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2024) & (K MT)
    Table 67. Europe Interventional X-ray Contrast and Imaging Agents Sales by Application (2025-2030) & (K MT)
    Table 68. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Interventional X-ray Contrast and Imaging Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Interventional X-ray Contrast and Imaging Agents Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2024) & (K MT)
    Table 74. Europe Interventional X-ray Contrast and Imaging Agents Sales by Country (2025-2030) & (K MT)
    Table 75. China Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2024) & (K MT)
    Table 76. China Interventional X-ray Contrast and Imaging Agents Sales by Type (2025-2030) & (K MT)
    Table 77. China Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Interventional X-ray Contrast and Imaging Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2024) & (K MT)
    Table 80. China Interventional X-ray Contrast and Imaging Agents Sales by Application (2025-2030) & (K MT)
    Table 81. China Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Interventional X-ray Contrast and Imaging Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2024) & (K MT)
    Table 84. Asia Interventional X-ray Contrast and Imaging Agents Sales by Type (2025-2030) & (K MT)
    Table 85. Asia Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Interventional X-ray Contrast and Imaging Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2024) & (K MT)
    Table 88. Asia Interventional X-ray Contrast and Imaging Agents Sales by Application (2025-2030) & (K MT)
    Table 89. Asia Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Interventional X-ray Contrast and Imaging Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Interventional X-ray Contrast and Imaging Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Interventional X-ray Contrast and Imaging Agents Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Interventional X-ray Contrast and Imaging Agents Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Interventional X-ray Contrast and Imaging Agents Sales by Region (2019-2024) & (K MT)
    Table 95. Asia Interventional X-ray Contrast and Imaging Agents Sales by Region (2025-2030) & (K MT)
    Table 96. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2019-2024) & (K MT)
    Table 97. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Type (2025-2030) & (K MT)
    Table 98. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2019-2024) & (K MT)
    Table 101. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Application (2025-2030) & (K MT)
    Table 102. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2019-2024) & (K MT)
    Table 108. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales by Country (2025-2030) & (K MT)
    Table 109. Bracco Company Information
    Table 110. Bracco Description and Major Businesses
    Table 111. Bracco Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 112. Bracco Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Bracco Recent Developments
    Table 114. General Electric Company Information
    Table 115. General Electric Description and Major Businesses
    Table 116. General Electric Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 117. General Electric Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. General Electric Recent Developments
    Table 119. Guerbet Company Information
    Table 120. Guerbet Description and Major Businesses
    Table 121. Guerbet Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 122. Guerbet Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Guerbet Recent Developments
    Table 124. Fujifilm Visualsonics Company Information
    Table 125. Fujifilm Visualsonics Description and Major Businesses
    Table 126. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 127. Fujifilm Visualsonics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Fujifilm Visualsonics Recent Developments
    Table 129. Imax Company Information
    Table 130. Imax Description and Major Businesses
    Table 131. Imax Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 132. Imax Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Imax Recent Developments
    Table 134. J.B. Chemicals & Pharmaceuticals Company Information
    Table 135. J.B. Chemicals & Pharmaceuticals Description and Major Businesses
    Table 136. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 137. J.B. Chemicals & Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. J.B. Chemicals & Pharmaceuticals Recent Developments
    Table 139. Jodas Expoim Company Information
    Table 140. Jodas Expoim Description and Major Businesses
    Table 141. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 142. Jodas Expoim Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Jodas Expoim Recent Developments
    Table 144. Lantheus Medical Imaging Company Information
    Table 145. Lantheus Medical Imaging Description and Major Businesses
    Table 146. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 147. Lantheus Medical Imaging Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Lantheus Medical Imaging Recent Developments
    Table 149. Nano Therapeutics Company Information
    Table 150. Nano Therapeutics Description and Major Businesses
    Table 151. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 152. Nano Therapeutics Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Nano Therapeutics Recent Developments
    Table 154. Novalek Pharmaceuticals Company Information
    Table 155. Novalek Pharmaceuticals Description and Major Businesses
    Table 156. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 157. Novalek Pharmaceuticals Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Novalek Pharmaceuticals Recent Developments
    Table 159. Taejoon Pharm Company Information
    Table 160. Taejoon Pharm Description and Major Businesses
    Table 161. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 162. Taejoon Pharm Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Taejoon Pharm Recent Developments
    Table 164. Unijules Life Sciences Company Information
    Table 165. Unijules Life Sciences Description and Major Businesses
    Table 166. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 167. Unijules Life Sciences Interventional X-ray Contrast and Imaging Agents Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. Unijules Life Sciences Recent Developments
    Table 169. Key Raw Materials Lists
    Table 170. Raw Materials Key Suppliers Lists
    Table 171. Interventional X-ray Contrast and Imaging Agents Distributors List
    Table 172. Interventional X-ray Contrast and Imaging Agents Customers List
    Table 173. Interventional X-ray Contrast and Imaging Agents Market Trends
    Table 174. Interventional X-ray Contrast and Imaging Agents Market Drivers
    Table 175. Interventional X-ray Contrast and Imaging Agents Market Challenges
    Table 176. Interventional X-ray Contrast and Imaging Agents Market Restraints
    Table 177. Research Programs/Design for This Report
    Table 178. Key Data Information from Secondary Sources
    Table 179. Key Data Information from Primary Sources
List of Figures
    Figure 1. Interventional X-ray Contrast and Imaging Agents Product Picture
    Figure 2. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Interventional X-ray Contrast and Imaging Agents Market Share by Type in 2023 & 2030
    Figure 4. Iodinated Contrast Media Product Picture
    Figure 5. Barium-Based Contrast Media Product Picture
    Figure 6. Microbubble Contrast Media Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Interventional X-ray Contrast and Imaging Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Interventional X-ray Contrast and Imaging Agents Market Share by Application in 2023 & 2030
    Figure 10. Heart Disease
    Figure 11. Neurological
    Figure 12. Urology
    Figure 13. General Surgery
    Figure 14. Other
    Figure 15. Interventional X-ray Contrast and Imaging Agents Report Years Considered
    Figure 16. Global Interventional X-ray Contrast and Imaging Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Interventional X-ray Contrast and Imaging Agents Revenue 2019-2030 (US$ Million)
    Figure 18. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 19. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Region (2019-2030)
    Figure 20. Global Interventional X-ray Contrast and Imaging Agents Sales 2019-2030 ((K MT)
    Figure 21. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Region (2019-2030)
    Figure 22. US & Canada Interventional X-ray Contrast and Imaging Agents Sales YoY (2019-2030) & (K MT)
    Figure 23. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Interventional X-ray Contrast and Imaging Agents Sales YoY (2019-2030) & (K MT)
    Figure 25. Europe Interventional X-ray Contrast and Imaging Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. China Interventional X-ray Contrast and Imaging Agents Sales YoY (2019-2030) & (K MT)
    Figure 27. China Interventional X-ray Contrast and Imaging Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Asia (excluding China) Interventional X-ray Contrast and Imaging Agents Sales YoY (2019-2030) & (K MT)
    Figure 29. Asia (excluding China) Interventional X-ray Contrast and Imaging Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales YoY (2019-2030) & (K MT)
    Figure 31. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. The Interventional X-ray Contrast and Imaging Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 33. The Top 5 and 10 Largest Manufacturers of Interventional X-ray Contrast and Imaging Agents in the World: Market Share by Interventional X-ray Contrast and Imaging Agents Revenue in 2023
    Figure 34. Global Interventional X-ray Contrast and Imaging Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 35. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
    Figure 36. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
    Figure 37. Global Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
    Figure 38. Global Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
    Figure 40. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
    Figure 41. US & Canada Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
    Figure 42. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
    Figure 43. US & Canada Interventional X-ray Contrast and Imaging Agents Revenue Share by Country (2019-2030)
    Figure 44. US & Canada Interventional X-ray Contrast and Imaging Agents Sales Share by Country (2019-2030)
    Figure 45. U.S. Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 46. Canada Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 47. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
    Figure 48. Europe Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
    Figure 49. Europe Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
    Figure 50. Europe Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
    Figure 51. Europe Interventional X-ray Contrast and Imaging Agents Revenue Share by Country (2019-2030)
    Figure 52. Europe Interventional X-ray Contrast and Imaging Agents Sales Share by Country (2019-2030)
    Figure 53. Germany Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 54. France Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 55. U.K. Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 56. Italy Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 57. Russia Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 58. China Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
    Figure 59. China Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
    Figure 60. China Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
    Figure 61. China Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
    Figure 63. Asia Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
    Figure 64. Asia Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
    Figure 65. Asia Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
    Figure 66. Asia Interventional X-ray Contrast and Imaging Agents Revenue Share by Region (2019-2030)
    Figure 67. Asia Interventional X-ray Contrast and Imaging Agents Sales Share by Region (2019-2030)
    Figure 68. Japan Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 69. South Korea Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 70. China Taiwan Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 71. Southeast Asia Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 72. India Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 73. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Revenue Share by Country (2019-2030)
    Figure 78. Middle East, Africa and Latin America Interventional X-ray Contrast and Imaging Agents Sales Share by Country (2019-2030)
    Figure 79. Brazil Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 80. Mexico Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 81. Turkey Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 82. Israel Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 83. GCC Countries Interventional X-ray Contrast and Imaging Agents Revenue (2019-2030) & (US$ Million)
    Figure 84. Interventional X-ray Contrast and Imaging Agents Value Chain
    Figure 85. Interventional X-ray Contrast and Imaging Agents Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture